N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Intelligent Sexual Health Information Support System for Gynecological Cancer Patients

Sponsor: Chang Gung Memorial Hospital • ClinicalTrials.gov ID: NCT07794098

Registry updated: 2026-09-11
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This study aims to develop the LillyBot Smart Sexual Health Consultation System, designed to meet the sexual health learning and consultation needs of gynecological cancer (GC) patients in Taiwan. Grounded in the Transtheoretical Model (TTM), this system integrates AI chatbot technology and mobile health (mHealth) to provide real-time, personalized sexual health education and consultations, ultimately improving the overall sexual well-being of GC patients.

Interventions

  • Intelligent Sexual Health Information Support with Proactive Nurse Researcher Contact (Other)
    The experimental group A will receivereceive the intelligent sexual health information support system along with proactive nurse researcher (registered nurse) contact.Data will be collected at baseline (T0), one month post-intervention (T1), and three months (T2) to evaluate the intervention's effectiveness.
  • Intelligent Sexual Health Information Support with Safety-Triggered Nurse Researcher Contact (Other)
    The experimental group B will receive the intelligent sexual health information support system with nurse researcher contact only upon a triggered safety alert.Data will be collected at baseline (T0), one month post-intervention (T1), and three months (T2) to evaluate the intervention's effectiveness.
  • Usual Gynecologic Cancer Care (Other)
    The control group will receive Usual Gynecologic Cancer Care.Data will be collected at baseline (T0), one month post-intervention (T1), and three months (T2) to evaluate the intervention's effectiveness.

Eligibility criteria

Inclusion Criteria: * Women diagnosed with gynecologic cancer within 6 months prior to enrollment. * Women receiving cancer treatment at the recruiting hospital. * Aged 20 to 70 years, inclusive. * Have a regular partner. * Possesses and is able to use an internet-enabled mobile device (such as a smartphone or iPad). * Able to clearly communicate and read/write in Mandarin or Taiwanese. Exclusion Criteria: * History of other malignant tumors. * Intellectual disability or mental disorders.

Conditions

Sexual and Reproductive Health Gynecologic Cancer Survivors

Locations

  • Cheng Gung Memorial Hospital — Taoyuan, Guishan, Taiwan
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record